IRVINE, Calif., Oct. 4, 2016/PRNewswire-iReach/ — joimax®, the worldwide acting German designer and advertiser of advancements and preparing techniques for endoscopic insignificantly intrusive spinal surgery, will again display at Eurospine 2016 occurring from October 5 – 7 in Berlin. Amid the gathering, joimax®will dispatch two new items – the MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy Set and its new Intracs® Interaoperative Navigation Tracking and Control System.
MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy is produced for the treatment of the Sacroiliac Joint Syndrome (SIJS), which has been rediscovered as a noteworthy back agony generator as of late. This sort of torment is usually felt in the lower back, the gluteal area, the hip and thigh and can even emanate into the leg and foot. Until the 1930s, SI-Joint was the primary purpose behind low back torment, yet since 1934 the emphasis has been on plate herniation. As indicated by late reviews, 15 to 25% of all low back agony is brought on by the SI-Joint and up to 43% in patients having experienced lumbosacral combination. MultiZYTE® SI joimax® now offers a very much created and enduring treatment alternative for this malady.
The Intracs® Interaoperative Navigation Tracking and Control System was created in collaboration between joimax® GmbH Karlsruhe and fiagon GmbH in Berlin, both situated in Germany. With the Intracs® framework, joimax® instruments can be explored straightforwardly at the tip utilizing Fiagons "chip at the tip" innovation which permits following of instruments with a measurement in the 1mm territory. The Intracs ® Navigation and Monitor Unit is incorporated in the joimax® Endoscopic Tower and every fundamental apparatus are custom fitted for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) techniques and for insignificantly intrusive adjustment strategies, as EndoLIF® and Percusys®. The principle elements of the Intracs® framework are needle route through Vector-Tip-Target handling devices, the converging of 2D X-Rays with 3D-pictures of a patient's CT or MRI examines, and the steady introduction control of any endoscope utilized as a part of joimax methods.
"With these two new improvements we are in the position to upgrade our endoscopic insignificantly intrusive item portfolio, driving selection rates to meet new statures. With the world exceptional Intracs® framework, route is presently speedier, more secure and more exact than any time in recent memory utilizing an electromagnetic (EM) field. Radiation introduction for both, patients and specialists will be altogether diminished," says Wolfgang Ries, CEO and organizer of joimax®. "Furthermore the expectation to learn and adapt for all spinal endoscopic methods offered by joimax® will now be altogether decreased and the fast development of every one of these procedures is currently all around layed-out," he proceeds.
About joimax®
Established in Karlsruhe, Germany, in 2001, joimax® is the main engineer and advertiser of finish frameworks for endoscopic insignificantly obtrusive spinal surgery. With TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression systems, MultiZYTE® RT (e.g. for rhizotomy) and with MultiZYTE® SI for SI-Joint treatment or with EndoLIF®and Percusys® for negligibly obtrusive endoscopic helped adjustments, demonstrated endoscopic frameworks are given that, together, cover an entire assortment of signs.
In strategies for herniated plate, stenosis, torment treatment or spinal adjustment treatment, specialists use joimax® advances to work through little entry points – under nearby or full soporific – by means of tissue and muscle-saving halls through regular openings into the spinal waterway (e.g. intervertebral foramen, the "Kambin triangle"). For more data visit www.joimax.com
Media Contact: Melissa Brumley, joimax® Inc., 001 949 859 3472, Melissa.brumley@joimaxusa.com
News conveyed by PR Newswire iReach: https://ireach.prnewswire.com
MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy is produced for the treatment of the Sacroiliac Joint Syndrome (SIJS), which has been rediscovered as a noteworthy back agony generator as of late. This sort of torment is usually felt in the lower back, the gluteal area, the hip and thigh and can even emanate into the leg and foot. Until the 1930s, SI-Joint was the primary purpose behind low back torment, yet since 1934 the emphasis has been on plate herniation. As indicated by late reviews, 15 to 25% of all low back agony is brought on by the SI-Joint and up to 43% in patients having experienced lumbosacral combination. MultiZYTE® SI joimax® now offers a very much created and enduring treatment alternative for this malady.
The Intracs® Interaoperative Navigation Tracking and Control System was created in collaboration between joimax® GmbH Karlsruhe and fiagon GmbH in Berlin, both situated in Germany. With the Intracs® framework, joimax® instruments can be explored straightforwardly at the tip utilizing Fiagons "chip at the tip" innovation which permits following of instruments with a measurement in the 1mm territory. The Intracs ® Navigation and Monitor Unit is incorporated in the joimax® Endoscopic Tower and every fundamental apparatus are custom fitted for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) techniques and for insignificantly intrusive adjustment strategies, as EndoLIF® and Percusys®. The principle elements of the Intracs® framework are needle route through Vector-Tip-Target handling devices, the converging of 2D X-Rays with 3D-pictures of a patient's CT or MRI examines, and the steady introduction control of any endoscope utilized as a part of joimax methods.
"With these two new improvements we are in the position to upgrade our endoscopic insignificantly intrusive item portfolio, driving selection rates to meet new statures. With the world exceptional Intracs® framework, route is presently speedier, more secure and more exact than any time in recent memory utilizing an electromagnetic (EM) field. Radiation introduction for both, patients and specialists will be altogether diminished," says Wolfgang Ries, CEO and organizer of joimax®. "Furthermore the expectation to learn and adapt for all spinal endoscopic methods offered by joimax® will now be altogether decreased and the fast development of every one of these procedures is currently all around layed-out," he proceeds.
About joimax®
Established in Karlsruhe, Germany, in 2001, joimax® is the main engineer and advertiser of finish frameworks for endoscopic insignificantly obtrusive spinal surgery. With TESSYS® (transforaminal), iLESSYS® (interlaminar) and CESSYS® (cervical) for decompression systems, MultiZYTE® RT (e.g. for rhizotomy) and with MultiZYTE® SI for SI-Joint treatment or with EndoLIF®and Percusys® for negligibly obtrusive endoscopic helped adjustments, demonstrated endoscopic frameworks are given that, together, cover an entire assortment of signs.
In strategies for herniated plate, stenosis, torment treatment or spinal adjustment treatment, specialists use joimax® advances to work through little entry points – under nearby or full soporific – by means of tissue and muscle-saving halls through regular openings into the spinal waterway (e.g. intervertebral foramen, the "Kambin triangle"). For more data visit www.joimax.com
Media Contact: Melissa Brumley, joimax® Inc., 001 949 859 3472, Melissa.brumley@joimaxusa.com
News conveyed by PR Newswire iReach: https://ireach.prnewswire.com
No comments:
Post a Comment
Note: only a member of this blog may post a comment.